Advertisement
Research Brief|Articles in Press

Increasing Use of Cannabis for Medical Purposes among US Residents, 2013-2020

  • Taeho Greg Rhee
    Correspondence
    Corresponding author: Greg Rhee, PhD, Yale School of Medicine; 100 York St, Ste 2J, New Haven, CT 06511 Phone: +1-860-679-5487
    Affiliations
    Department of Psychiatry, Yale School of Medicine, New Haven, CT

    VA New England Mental Illness, Research, Education and Clinical Center (MIRECC), VA Connecticut Healthcare System, West Haven, CT, USA

    Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT
    Search for articles by this author
  • Robert A. Rosenheck
    Affiliations
    Department of Psychiatry, Yale School of Medicine, New Haven, CT

    VA New England Mental Illness, Research, Education and Clinical Center (MIRECC), VA Connecticut Healthcare System, West Haven, CT, USA
    Search for articles by this author

      Abstract

      Introduction

      Cannabis use for medical purposes is legalized across 39 states and the District of Columbia in the US. The objective of this study was to evaluate temporal trends and correlates of cannabis use for medical purposes in the US.

      Methods

      Data from 2013-2020 National Survey on Drug Use and Health (NSDUH) were used. Since 2013, medical cannabis use has been assessed using a dichotomous question asking whether any medical cannabis use was recommended by a doctor among those who used cannabis in the past 12 months. A modified Poisson model was used to estimate the average annual percent change (AAPC) of medical cannabis use from 2013 to 2020. The analyses were repeated for key socio-demographic and clinical subgroups. Data were analyzed from September to November, 2022.

      Results

      The prevalence of US residents using cannabis for medical purposes increased significantly from 1.2% in 2013-2014 to 2.5% in 2019-2020, with an AAPC of 12.9% (95% confidence interval [CI], 10.4-15.5%), and many of socio-demographic and clinical subgroups showed similar significant increases in cannabis use for medical purposes. In the multivariable-adjusted model, living in a state that legalized medical cannabis remained significantly associated with medical cannabis use (adjusted odds ratio, 4.10; 95% CI, 3.68-4.56).

      Conclusions

      The study documents a continued nationwide increase in use of cannabis for diverse medical purposes between 2013 and 2020, two decades after the first state passed legalizing legislation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect